A detailed history of Brown Financial Advisory transactions in Abb Vie Inc. stock. As of the latest transaction made, Brown Financial Advisory holds 1,765 shares of ABBV stock, worth $291,207. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,765
Previous 1,765 -0.0%
Holding current value
$291,207
Previous $302,000 15.23%
% of portfolio
0.25%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $6,232 - $7,101
-39 Reduced 2.16%
1,765 $321,000
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $242,114 - $277,689
1,804 New
1,804 $242,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Brown Financial Advisory Portfolio

Follow Brown Financial Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Financial Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Brown Financial Advisory with notifications on news.